Targeting TGF-β pathway with  COVID-19 Drug Candidate  ARTIVeda/PulmoHeal Accelerates  Recovery from Mild-Moderate  COVID-19
            
                            - Home
- Paper Publication
- Targeting TGF-β pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19